ORIC
ORIC Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$11.90
+0.14 ▲ +1.19%
🌙 3월 13일 4:11 PM ET (한국 3/14 05:11)
$11.90
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -1.51 | Insider Own | 43.27% | Shs Outstand | 0.10B | Perf Week | -13.2% |
| Market Cap | 1.19B | Forward P/E | - | EPS next Y | -9.86% | Insider Trans | -0.86% | Shs Float | 0.06B | Perf Month | 16.67% |
| Enterprise Value | 0.92B | PEG | - | EPS next Q | -0.32 | Inst Own | 78.75% | Short Float | 38.28% | Perf Quarter | 19% |
| Income | -0.13B | P/S | - | EPS this Y | 5% | Inst Trans | 16.57% | Short Ratio | 13.05 | Perf Half Y | 9.58% |
| Sales | 0.00B | P/B | 3.05 | EPS next 5Y | -3.79% | ROA | -37.65% | Short Interest | 21.79M | Perf YTD | 45.48% |
| Book/sh | 3.9 | P/C | 4.24 | EPS past 3/5Y | 13.1% 15.18% | ROE | -41.27% | 52W High | -20.29% ($14.93) | Perf Year | 54.55% |
| Cash/sh | 2.8 | P/FCF | - | Sales past 3/5Y | - | ROIC | -33.33% | 52W Low | 205.51% ($3.90) | Perf 3Y | 161.54% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 17.22% | Gross Margin | - | Volatility(W/M) | 9.64% 8.03% | Perf 5Y | -61.07% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 14.13 | EPS Q/Q | 42.13% | Profit Margin | - | RSI (14) | 48.39 | Recom | 1.2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 14.13 | Sales Q/Q | - | SMA20 | -3.95% ($12.39) | Beta | 1.39 | Target Price | $21.23 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2000000 | SMA50 | 6.25% ($11.2) | Rel Volume | 0.95 | Prev Close | $11.76 |
| Employees | 104 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 11.66% - | SMA200 | 9.41% ($10.88) | Avg Volume(3M) | 1.67M | Price | $11.9 |
| IPO | 2020/4/24 | Option/Short | Yes/Yes | Trades | 8076 | Volume | 1,579,517 | Change | 1.19% |
뉴스 로딩 중...